Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications
Article in International Journal of Molecular Sciences (April 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
The Key Genetic Determinants Behind the Phenotypic Heterogeneity of HbE/β-thalassemia Patients and the Probable Management Strategy
Book chapter (November 2023)
Mutational analysis of hemoglobin genes and functional characterization of detected variants, through in-silico analysis, in Pakistani beta-thalassemia major patients
Article in Scientific Reports (August 2023)